Effects of 1,25(OH)2D3 on lipid droplet growth in adipocytes

被引:12
|
作者
Xiang, Wei [1 ]
Cheng, Shi [2 ]
Zhou, Yong [3 ]
Ma, Ling [4 ]
机构
[1] Changzhou Tradit Chinese Med Hosp, Dept Nutr & Diet, Changzhou, Jiangsu, Peoples R China
[2] Xinjiang Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Urumqi, Peoples R China
[3] Southwest Med Univ, Dept Med Cell Biol & Genet, Coll Preclin Med, Luzhou, Peoples R China
[4] Southwest Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Luzhou 646000, Szechwan, Peoples R China
关键词
1; 25‐ dihydroxyvitamin D-3; cell hypertrophy; lipid droplet; VITAMIN-D; TRIACYLGLYCEROL SYNTHESIS; HEPATIC STEATOSIS; ADIPOSE-TISSUE; D-RECEPTOR; BROWN; ADIPOGENESIS; STORAGE; PROTEINS; FAMILY;
D O I
10.1002/biof.1610
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to explore the effects of 1,25(OH)(2)D-3 on lipid droplet (LD) growth in 3T3-L1 adipocytes of hypertrophy model. Cocktail method was used to induce differentiation in 3T3-L1 cells. After 8 days, the cells were modeled by 100, 300, 600, and 900 mu M palmitic acid (PA) for 24 hr. The best concentration of modeling was screened by MTT results and triglycerides (TG) content. The model cells were intervened by 1, 10, and 100 nM 1,25(OH)(2)D-3 for 24 hr. Then, the TG content of cells were detected and stained by oil red O. The diameter and quantity of LDs were analyzed. mRNA relative expression levels of genes related to LD (CIDE-a, Fsp27, PLIN-1), upstream response factor (PPAR-alpha, PPAR-gamma, and VDR), and TG metabolism (long chain acyl-CoA synthetase 3, 1-acylglycerol-3-phosphate O-acyltransferase 1, adipose triglyceride lipase, diacylglycerol acyltransferase 1, diacylglycerol acyltransferase 2, glycerol-3-phosphate O-acyltransferase 3, glycerol-3-phosphate O-acyltransferase 4, hormone-sensitive lipase, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetyl glucosaminyl transferase, phosphatidic acid phosphatase, and uncoupling protein-1) were detected by RT-qPCR. A total of 300 mu M PA was selected as the optimum concentration. Compared with model group, 10 and 100 nM 1,25(OH)(2)D-3 decreased the average diameter, increased the quantity of LDs, upregulated PPAR-alpha and PLIN-1 mRNA expression levels, and downregulated CIDE-a and Fsp27 mRNA expression levels significantly (p < .05). However, 1 nM 1,25(OH)(2)D-3 did not alter LD morphology and TG content. mRNA expression levels of long chain acyl-CoA synthetase 3, 1-acylglycerol-3-phosphate O-acyltransferase 1, diacylglycerol acyltransferase 2, glycerol-3-phosphate O-acyltransferase 3, and glycerol-3-phosphate O-acyltransferase 4 in 10 and 100 nM groups were significantly lower than those in the model group (p < .05); mRNA expression levels of adipose triglyceride lipase, diacylglycerol acyltransferase 1, hormone-sensitive lipase, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetyl glucosaminyl transferase, phosphatidic acid phosphatase, and uncoupling protein-1 were significantly increased in the 100 nM group (p < .05). The 10 and 100 nM 1,25(OH)(2)D-3 can inhibit LD fusion, promote LD decomposition, reduce LD volume, and inhibit lipogenesis through the PPAR-alpha signaling pathway.
引用
收藏
页码:943 / 954
页数:12
相关论文
共 50 条
  • [21] GONADAL 1,25(OH)2D3 RECEPTOR AND ACTION OF 1,25(OH)2D3 ON LH STIMULATED TESTICULAR AND OVARIAN CAMP RESPONSE
    MERKE, J
    KREUSSER, W
    RITZ, E
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1982, 17 (03): : R111 - R111
  • [22] DUODENAL MUCOSA IN UREMIC MAN - EFFECTS OF 1,25(OH)2D3
    GOLDSTEIN, DA
    HOROWITZ, RE
    PETIT, S
    HALDIMANN, B
    MASSRY, SG
    CLINICAL RESEARCH, 1979, 27 (01): : A45 - A45
  • [23] EFFECTS OF 1,25(OH)2D3 ON PARATHYROID-HORMONE SECRETION
    CANTLEY, LK
    RUSSELL, J
    LETTIERI, D
    SHERWOOD, LM
    CLINICAL RESEARCH, 1984, 32 (03): : A704 - A704
  • [24] EFFECTS OF 1,25(OH)2D3 ON HUMAN LYMPHOCYTES-T
    BARKER, S
    NUNN, J
    KARMALI, R
    HEWISON, M
    FRAHER, LJ
    KATZ, D
    ORIORDAN, JLH
    BONE, 1986, 7 (04) : 303 - 303
  • [25] DUODENAL MUCOSA IN UREMIC MAN - EFFECTS OF 1,25(OH)2D3
    GOLDSTEIN, DA
    HOROWITZ, RE
    PETIT, S
    HALDIMANN, B
    MASSRY, SG
    KIDNEY INTERNATIONAL, 1978, 14 (06) : 652 - 652
  • [26] SOME LONG-TERM EFFECTS OF 1,25 DIHYDROXYCHOLECALCIFEROL (1,25(OH)2D3) IN MAN
    HENDERSO.RG
    LEDINGHA.JG
    OLIVER, DO
    SMALL, DG
    RUSSELL, RGG
    SMITH, R
    WALTON, RJ
    NORMAN, AW
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1974, 46 (02): : P10 - P10
  • [27] 1,25(OH)2D3 AND 25-OHD3 IN THE TREATMENT OF RENAL OSTEODYSTROPHY - COMPARISON OF COMBINED VERSUS 1,25(OH)2D3 ADMINISTRATION ALONE
    COEN, G
    GALLUCCI, MT
    BONUCCI, E
    BALLANTI, P
    BIANCHI, AR
    BIANCHINI, G
    MATTEUCCI, MC
    MAZZAFERRO, S
    PICCA, S
    TAGGI, F
    CINOTTI, GA
    CASCIANI, CU
    MINERAL AND ELECTROLYTE METABOLISM, 1983, 9 (01) : 19 - 27
  • [28] Higher 25(OH)D2 Is Associated With Lower 25(OH)D3 and 1,25(OH)2D3
    Swanson, Christine M.
    Nielson, Carrie M.
    Shrestha, Smriti
    Lee, Christine G.
    Barrett-Connor, Elizabeth
    Jans, Ivo
    Cauley, Jane A.
    Boonen, Steven
    Bouillon, Roger
    Vanderschueren, Dirk
    Orwoll, Eric S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (08): : 2736 - 2744
  • [29] INVIVO REGULATION OF RENAL METABOLISM OF 25(OH)D3 IN RATS BY 1,25(OH)2D3 AND 24,25(OH)2D3
    TURNER, RT
    CALCIFIED TISSUE INTERNATIONAL, 1981, 33 (03) : 344 - 344
  • [30] 1,25(OH)2D3 AND RENAL-FUNCTION
    JENSEN, GF
    CHRISTIANSEN, C
    TRANSBOL, I
    ACTA MEDICA SCANDINAVICA, 1982, 211 (1-2): : 51 - 54